Loading...
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
In patients with a first unprovoked venous thromboembolism (VTE), adding computed tomography to a limited screening strategy does not improve the detection of occult cancer, according to a New England Journal of Medicine study.
Some 850 adults in Canada with unprovoked VTE were randomized to a limited screening strategy either alone or with CT of the abdomen and pelvis. Limited screening included basic blood testing (e.g., electrolytes, creatinine), chest radiography, and, depending on the patient's age and sex, mammography, Pap testing, and prostate cancer screening.
Within 1 year after randomization, cancer was diagnosed in 33 patients, with no significant difference between the groups. Of these cancers, 4 of 14 (29%) were initially missed by the limited screening strategy and 5 of 19 (26%) were missed by limited screening plus CT — again, not a significant difference. In addition, the groups did not differ in the average time to detection of occult cancer (4 months) or in cancer-related mortality.
Allan Brett of NEJM Journal Watch General Medicine commented, "These results suggest that CT scanning to search for occult abdominal or pelvic cancer is unnecessary in patients with unprovoked VTE whose general evaluation is negative for cancer. The 1-year follow-up was probably sufficient, since one would expect most cancers causing VTE to become symptomatic during that interval."
Comment
LINK(S):
NEJM article (Free)
Background: NEJM Journal Watch Oncology and Hematology coverage of venous thromboembolisn and occult cancer (Your NEJM Journal Watch registration required)